Your liver works hard every day, so it's natural to wonder what a daily coffee habit means for it.
This is one of the most consistent areas of coffee research. Study after study, across different countries and designs, has found that coffee drinkers tend to have lower rates of several liver conditions. Below we walk through what the biggest studies found, how strong the evidence is, and what it does and doesn't mean.
As always: these are observational associations with coffee drinking in general. They don't prove coffee caused the outcomes, they aren't claims about Edge Coffee, and coffee is not a substitute for medical care. If you have a liver condition, follow your clinician's guidance.
The biggest single study: half a million people
In the UK Biobank, researchers followed about 495,000 adults. Compared with non-drinkers, coffee drinkers had about 21% lower risk of chronic liver disease and about 49% lower risk of dying from chronic liver disease. The results were similar for decaf, instant, and ground coffee (Kennedy et al., BMC Public Health 2021).
That last detail matters. Because decaf showed similar associations, caffeine may not be the whole story. Coffee contains many other compounds, including chlorogenic acids, which are partly absorbed and partly converted by gut microbes into other phenolic metabolites (Del Rio et al., Nutrients 2010). Researchers are still working out which components, if any, explain the associations.
Cirrhosis: a striking dose-response pattern
A meta-analysis on cirrhosis, the late-stage scarring of the liver, found that each additional 2 cups of coffee a day was associated with about 44% lower cirrhosis risk (Kennedy et al., Aliment Pharmacol Ther 2016).
That's a big number, so it deserves a caveat: the authors reported high heterogeneity, meaning results varied quite a bit between the included studies. The direction was consistent, but the exact size of the association is less certain.
Liver cancer
A dose-response meta-analysis found that higher coffee intake was associated with a lower risk of hepatocellular carcinoma (Kennedy et al., BMJ Open 2017). An umbrella review of 112 meta-analyses also rated coffee as associated with a probable lower risk of several cancers (Grosso et al., Annu Rev Nutr 2017).
Fatty liver (NAFLD): mixed for risk, more consistent for fibrosis
Researchers have also looked closely at non-alcoholic fatty liver disease (NAFLD). Here, the picture is more nuanced:
- Risk of developing NAFLD: One meta-analysis of 11 studies found coffee drinkers had lower NAFLD risk (relative risk 0.77) (Hayat et al., Ann Hepatol 2021). But a later umbrella review and meta-analysis described the results for the general population as mixed (Kositamongkol et al., Front Pharmacol 2021).
- Fibrosis in people who already have NAFLD: This finding was more consistent. Among NAFLD patients, coffee drinking was associated with less liver fibrosis (scarring), with an odds ratio of 0.67 (Kositamongkol et al., 2021; Hayat et al., 2021).
So the honest summary: the evidence is mixed on whether coffee drinkers are less likely to develop fatty liver, and more consistent on the association with less fibrosis among people who have it.
How much coffee did these studies involve?
The cirrhosis analysis measured benefit in steps of 2 extra cups a day (Kennedy et al., 2016), and the UK Biobank compared coffee drinkers broadly with non-drinkers (Kennedy et al., 2021). Across coffee research generally, the most favorable associations tend to cluster around 3–4 cups a day (Poole et al., BMJ 2017). More isn't automatically better, and some groups should be careful with caffeine.
⚠️ Caution box: pregnancy and high caffeine intake
- Pregnancy. In a dose-response meta-analysis of prospective studies, each additional 100 mg of caffeine a day during pregnancy (around one cup of coffee) was associated with a 13% higher risk of low birth weight (Chen et al., BMC Med 2014). A second meta-analysis linked each additional 100 mg a day with about 7% higher risk of pregnancy loss; the authors called the evidence inconclusive but said avoiding high caffeine intake in pregnancy "appears prudent" (Chen et al., Public Health Nutr 2016). One review goes further and argues for avoiding caffeine in pregnancy, a position that remains debated (James, BMJ Evid Based Med 2021). If you're pregnant or trying to conceive, talk with your clinician about caffeine.
- Very high intake. In a UK Biobank analysis, drinking more than 6 cups a day was associated with 53% higher odds of dementia compared with 1–2 cups a day, along with smaller brain volumes (Pham et al., Nutr Neurosci 2022). More is not automatically better.
- Caffeine affects people differently. If you're sensitive, take medication, or have a health condition, check with your clinician. Want the ritual with much less caffeine? Try All Day Decaf.
A note on unfiltered coffee
One nuance from the trial data: cafestol, a compound found in unfiltered brews, raised serum cholesterol and the liver enzyme ALT in a randomized trial (Urgert et al., Am J Clin Nutr 1997). That's a small, older trial, but it's one reason paper-filtered coffee is a reasonable default for daily drinkers. More in why brew method matters.
What about what's in the coffee?
If you care about your liver, you probably care about what goes into your body, period. That's part of why we started Edge. Mycotoxins such as aflatoxins and ochratoxin A are mold byproducts that food-safety agencies monitor. WHO notes aflatoxin B1 is classified as a Group 1 human carcinogen (WHO mycotoxins fact sheet). A 2024 worldwide review found ochratoxin A levels in coffee were generally within safe exposure margins, and recommended controlling mold along the supply chain (Massahi et al., Food Addit Contam Part A 2024). We go a step further and use third-party lab testing for mold and mycotoxins. That's a quality choice, not a health claim. Learn how we test or read what the data say about mycotoxins in coffee.
The bottom line
Liver research is one of the most consistent chapters in the coffee story. Large studies associate coffee drinking with lower rates of chronic liver disease, cirrhosis, and liver cancer, and with less fibrosis among people with fatty liver, for decaf as well as regular coffee. The evidence is observational and mixed on fatty liver risk itself. Coffee isn't medicine, but if you enjoy it, these findings are encouraging context for your daily cup.
Try Edge Pure Health Coffee, All Day Decaf, or shop the collection.
FAQ
Is coffee good for your liver? Large studies associate coffee drinking with lower risk of chronic liver disease and cirrhosis (Kennedy et al., 2021; Kennedy et al., 2016). These are associations, not proof of cause.
Does decaf show the same liver associations? In the UK Biobank, results were similar for decaf, instant, and ground coffee (Kennedy et al., 2021).
Does coffee lower fatty liver risk? The evidence is mixed. One meta-analysis found lower risk (Hayat et al., 2021), while an umbrella review called it mixed. Coffee was more consistently associated with less fibrosis in people with NAFLD (Kositamongkol et al., 2021).
Should I start drinking coffee for my liver? These studies don't show that starting coffee changes outcomes. Talk with your clinician about liver health.
General information about coffee research. Not medical advice. These findings describe coffee drinking in general and are not claims about Edge Coffee.
Sources
- Kennedy OJ et al. BMC Public Health. 2021. https://pubmed.ncbi.nlm.nih.gov/34154561/ (doi:10.1186/s12889-021-10991-7)
- Kennedy OJ et al. Aliment Pharmacol Ther. 2016. https://pubmed.ncbi.nlm.nih.gov/26806124/ (doi:10.1111/apt.13523)
- Kennedy OJ et al. BMJ Open. 2017. https://pubmed.ncbi.nlm.nih.gov/28490552/
- Hayat U et al. Ann Hepatol. 2021. https://pubmed.ncbi.nlm.nih.gov/32920163/ (doi:10.1016/j.aohep.2020.08.071)
- Kositamongkol C et al. Front Pharmacol. 2021. https://pubmed.ncbi.nlm.nih.gov/34966282/ (doi:10.3389/fphar.2021.786596)
- Grosso G et al. Annu Rev Nutr. 2017. https://pubmed.ncbi.nlm.nih.gov/28826374/
- Del Rio D et al. Nutrients. 2010. https://pubmed.ncbi.nlm.nih.gov/22254058/ (doi:10.3390/nu2080820)
- Poole R et al. BMJ. 2017. https://pubmed.ncbi.nlm.nih.gov/29167102/
- Urgert R et al. Am J Clin Nutr. 1997. https://pubmed.ncbi.nlm.nih.gov/9022539/
- WHO. Mycotoxins fact sheet. https://www.who.int/news-room/fact-sheets/detail/mycotoxins
- Massahi T et al. Food Addit Contam Part A. 2024. https://pubmed.ncbi.nlm.nih.gov/39259858/
- Chen LW et al. BMC Med. 2014. https://pubmed.ncbi.nlm.nih.gov/25238871/
- Chen LW et al. Public Health Nutr. 2016. https://pubmed.ncbi.nlm.nih.gov/26329421/
- James JE. BMJ Evid Based Med. 2021. https://pubmed.ncbi.nlm.nih.gov/32843532/
- Pham K et al. Nutr Neurosci. 2022. https://pubmed.ncbi.nlm.nih.gov/34165394/